-
No recommendation on mix and match of Covid-19 doses till now
The World Health Organization has also not given any specific recommendation on mix and match of vaccines
-
Serum Institute to start manufacturing Sputnik vaccine in September
As part of the technology transfer process, SII has already received cell and vector samples from the Gamaleya Center.
-
Sputnik V roll out delayed in Delhi
According to Gamaleya and the RDIF, Sputnik V has demonstrated an efficacy rate of 92 per cent
-
Sputnik V: Russian Direct Investment Fund says India to produce over 850 million doses
Sputnik V will be the third vaccine to be used in India
-
Dr Reddy’s receives DCGI approval for COVID-19 vaccine Sputnik V for restricted emergency use
In September 2020, Dr Reddy's had partnered with the Russian Direct Investment Fund (RDIF) to conduct the clinical trials of Sputnik V and distribute
